DBV Tech (DBVT)
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its...
- Open
- 13.750
- High
- 13.830
- Low
- 13.580
- Prev. Close
- 13.540
- Volume
- 149.72K
- Turnover
- 2.06M
- Avg Price
- 13.735
- Bid/Ask Ratio
- -33.33%
- Amplitude
- 1.85%
- 52wk High
- 26.185
- Volume Ratio
- 0.54
- Turnover Ratio
- 0.48%
DBV Tech Analyst Rating
View moreForecast & Rating
Jul 21, 2026Price forecast
$40.72196.12%
Forecast & RatingBuy
6analysts
- Strong buy66.67%
- Buy16.67%
- Hold0.00%
- Sell16.67%
- Strong sell0.00%
News
- PUBT · Aug 28 at 10:47 AM
JPMorgan Chase holds 9.39% stake in DBV Technologies
- PUBT · Aug 27 at 10:54 AM
Deep Track Biotechnology Master Fund discloses net short position in DBV Technologies
- PUBT · Aug 27 at 09:07 AM
JPMorgan lifts DBV Technologies stake to 13.73%
- PUBT · Aug 26 at 08:40 AM
WorldQuant discloses net short position in DBV Technologies shares
- PUBT · Aug 25 at 06:14 AM
JPMorgan cuts DBV Technologies stake below 10% to 9.18%
- PUBT · Aug 24 at 09:59 AM
JPMorgan cuts DBV Technologies stake to 9.18%
